Page last updated: 2024-08-21

butyramide and Diabetes Mellitus, Type 2

butyramide has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CN; Chao, YS; Chen, CT; Chen, X; Cheng, JH; Chien, CH; Coumar, MS; Han, CH; Hsieh, HP; Hsu, LJ; Hsu, T; Huang, YW; Jiaang, WT; Tsai, TY; Wu, HY; Wu, SH	1

Other Studies

1 other study(ies) available for butyramide and Diabetes Mellitus, Type 2

Article	Year
3-[2-((2S)-2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes. Bioorganic & medicinal chemistry letters, 2007, Mar-01, Volume: 17, Issue:5 Topics: Adamantane; Adenosine Deaminase Inhibitors; Amides; Aniline Compounds; Animals; Benzylamines; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glycoproteins; Inhibitory Concentration 50; Nitriles; Phenethylamines; Pyrrolidines; Rats; Rats, Wistar; Structure-Activity Relationship; Vildagliptin	2007

Article

Year

3-[2-((2S)-2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes.

Bioorganic & medicinal chemistry letters, 2007, Mar-01, Volume: 17, Issue:5

Topics: Adamantane; Adenosine Deaminase Inhibitors; Amides; Aniline Compounds; Animals; Benzylamines; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glycoproteins; Inhibitory Concentration 50; Nitriles; Phenethylamines; Pyrrolidines; Rats; Rats, Wistar; Structure-Activity Relationship; Vildagliptin

2007